Biotech firm Amyris files for bankruptcy
10/08/2023 02:54
Aug 9 (Reuters) - Biotech firm Amyris Inc AMRS.O on
Wednesday said it has filed for Chapter 11 bankruptcy in a U.S.
court and is planning to sell its consumer brands to improve the
company's liquidity position.
Amyris said it has secured a $190 million financing
commitment to support day-to-day operations.
(Reporting by Juby Babu in Bengaluru; Editing by Rashmi Aich)
((Juby.Babu@thomsonreuters.com;))
Recent news on Amyris
See all newsBrief: Amyris Announces Kathy Fortmann As New CEO
Brief: Amyris Announced Termination Or Separation Of About 80 Employees on Feb 7
Brief: Amyris- Related To Sale Of Some Consumer Brands, Announces Termination/ Separation Of About 220 Employees
Brief: Amyris On December 12, Debtors Entered Into An Amendment To And Restatement Of That Certain Plan Support Agreement, Dated October 12, 2023
Brief: Amyris Inc On August 10, Received Notice Of Delisting From Nasdaq